Camilo, Zerica .

HRN: 22-01-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
CEFUROXIME 1.5GM (VIAL)
12/07/2022
12/14/2022
IV
113 Mg
Q 8 H
PCAP C
Waiting Final Action 
12/12/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/12/2022
12/19/2022
IV
113mg
Q8H
PCAP C
Waiting Final Action 
12/12/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/12/2022
12/19/2022
IVT
34 Mg
Q8H
AGE With Severe Dehydration
Waiting Final Action 
12/18/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/18/2022
12/25/2022
IV
34mg
Q8
Sepsis
Waiting Final Action 
12/20/2022
CEFTAZIDIME 1GM (VIAL)
12/20/2022
12/27/2022
IVT
140 Mg
8 Hrs
RT PCR Confirmed COVID 19 Pneumonia
Waiting Final Action 
12/20/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
12/20/2022
12/27/2022
IVT
40 Mg Loading, 20 Mg Maintaining
24 Hrs
RT PCR Confirmed COVID 19 Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: